Drug Delivery Letters

Scopus Cite Score: 1.1

Indexed in: Scopus, Cabell's Directory/Journalytics

View All
Aims and Scope:
Drug Delivery Letters publishes short papers and mini-reviews in all important aspects of drug delivery, gene delivery, and drug targeting. Short papers report seminal results and research approaching conclusion of importance in the field. The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The manuscript submission process is fully electronic to ensure rapid publication of research results.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Maria Camilla BergonziDepartment of Chemistry
    University of Florence
    Florence
    Italy

ISSN: 2210-3031 (Print)

eISSN: 2210-304X (Online)

Special Issues With Active Call for Papers

Submission closes on: Feb 18, 2027
Hybrid Nano-Formulations for Spatiotemporal, Multi-Target Therapeutics: Innovations, Mechanisms, and Clinical Horizons.

Hybrid nano-formulations represent a rapidly evolving frontier in drug delivery, enabling precise spatiotemporal control and multi-target therapeutic action. By integrating organic, inorganic, polymeric, lipid-based, and biomolecular components into a single platform, these systems overcome limitations of conventional therapies such as poor bioavailability, off-target toxicity, and limited therapeutic efficacy. This thematic issue focuses on recent innovations in hybrid nano-formulations designed for site-specific, stimuli-responsive, and time-controlled drug release across diverse disease conditions. It highlights underlying mechanisms of... see more

Guest Editor(s): Dr. Khalid Bashir Mir
Co-Guest Editor(s): Dr. Faheem Hyder Pottoo,Dr. Mohit Agrawal,Dr. Narender Yadav
Start Submission
Submission closes on: May 22, 2026
Nano Formulations and Advanced Drug Delivery Approaches for Next-Generation Cancer Therapeutics.

The field of oncology is undergoing a transformative shift with the integration of nanotechnology and advanced drug delivery systems aimed at enhancing the precision, efficacy, and safety of cancer therapeutics. Nano formulations—including liposomes, polymeric nanoparticles, dendrimers, micelles, and inorganic nanocarriers—offer unique physicochemical properties such as high surface area, tunable size, and controlled drug release, which allow for targeted delivery and improved bioavailability of chemotherapeutic agents. These systems are designed to overcome traditional challenges like poor... see more

Guest Editor(s): Dr. Khalid Bashir Mir
Co-Guest Editor(s): Dr. Faheem Hyder Pottoo,Dr. Gopal Agrawal,Dr. Mohit Agrawal,Dr. Narender Yadav
Start Submission